Clinical Stage IV Gastric Cancer AJCC v8 Recruiting Phase 1 Trials for Daunorubicin (DB00694)

IndicationStatusPhase
DBCOND0113387 (Clinical Stage IV Gastric Cancer AJCC v8)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04329494PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric CancerTreatment